Meeting medical needs through public-private collaboration
This article was originally published in Scrip
Getting new drugs and vaccines to those who really need them is a problem that has taxed regulators, industry and activists for many years. It affects a wide range of areas, from drugs for neglected tropical diseases via medicines for TB and other infectious diseases, to targeted treatments for specific populations such as cancer patients. And while some successes have been achieved in meeting these unfilled needs, there is still some way to go.